|
Medeon Biodesign Announces Successful Clinical Use of AbClose Port Site Closure Device in the USA
Medeon Biodesign, Inc. is pleased to announce that its innovative laparoscopic port site closure device, AbClose, successfully closed more than 50 wounds in a variety of laparoscopic surgeries.
|
|
UPM Raflatac introduces new labeling solutions for medical device and healthcare applications in CPhI
UPM Raflatac will be present at the CPhl Innopack exhibition on 24-26 October 2017 in Frankfurt, Germany. Visitors will have the opportunity to discuss market developments and the latest solutions...
|
|